Skip to content

Clinical trials

Observational Myelodysplastic Syndromes trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Observational Clear all

218 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20032
20044
20051
20067
200717
200812
20098
201014
20117
20125
201310
20149
20155
201611
20179
20189
20198
202014
20218
20227
20238
202416
20258
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed97
Recruiting44
Unknown status35
Terminated15
Withdrawn8
Active, not recruiting8
Not yet recruiting7
Enrolling by invitation4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene14
Bristol-Myers Squibb11
National Cancer Institute (NCI)6
Fred Hutchinson Cancer Center5
Gruppo Italiano Malattie EMatologiche dell'Adulto5
M.D. Anderson Cancer Center5
City of Hope Medical Center4
Dana-Farber Cancer Institute4
Assistance Publique - Hôpitaux de Paris3
Centre Hospitalier Universitaire, Amiens3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes218
Leukemia, Myeloid, Acute79
Leukemia49
Multiple Myeloma40
Lymphoma36
Precursor Cell Lymphoblastic Leukemia-Lymphoma34
Myeloproliferative Disorders32
Leukemia, Lymphocytic, Chronic, B-Cell28
Lymphoma, Non-Hodgkin28
Hodgkin Disease24

Trials

Showing 76 to 100 of 218. Each trial links to its page on Pharma Observatory.

118 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.